Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Ranbaxy: Buoyed by 'exclusivity' products - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Ranbaxy: Buoyed by 'exclusivity' products

May 12, 2010

Ranbaxy has announced its 1QCY10 results. The company has reported 75% YoY growth in sales and net profits of Rs 9.6 bn. Here is our analysis of the results.

Performance summary
  • Revenues grow by 75% YoY during the quarter primarily led by strong sales from 2 first-to-file (FTF) products in the US and growth in key geographies.
  • Several cost rationalization measures along with the 2 FTF products lead to an improvement in operating margins to 38% during the quarter.
  • With the company recording forex gains of Rs 4.5 bn as against forex losses of Rs 11.3 bn in 1QCY09, it posts a net profit of Rs 9.6 bn during the quarter as against a loss of Rs 7.6 bn in 1QCY09.
Financial performance: A snapshot
(Rs m) 1QCY09 1QCY10 Change
Net sales 15,771 27,671 75.4%
Expenditure 15,749 17,154 8.9%
Operating profit (EBDITA) 23 10,517  
EBDITA margin (%) 0.1% 38.0%  
Other income 457 399 -12.7%
Interest (net) 246 248 0.8%
Depreciation 639 1,005 57.3%
Profit before tax (405) 9,663  
Tax (4,101) 4,524  
Forex loss/(gain) 11,306 (4,492)  
Profit after tax/(loss) (7,610) 9,631  
Net profit margin (%) -48.3% 34.8%  
No. of shares (m) 420.4 420.5  
Diluted earnings per share (Rs)*   29.2  
P/E ratio (x)   15.5  

To Read the Full Story, Subscribe or Sign In
To Read the Full Story, Subscribe or Sign In

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Apr 1, 2015 (Close)


  • Track your investment in RANBAXY LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks